Novo Nordisk A/S
Copenhagen : NOVO B

October 19, 2012 08:12 ET

Novo Nordisk A/S: Tresiba® (insulin degludec) and Ryzodeg® (insulin degludec/insulin aspart) receive positive opinions from the European regulatory authorities

BAGSVAERD, DENMARK--(Marketwire - Oct 19, 2012) -

Company Announcement No 66 / 2012:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i)  the releases contained herein are protected by copyright and
     other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1650358]

Contact Information